Research Article
A Population-Based Clinical Trial of Irinotecan and Carboplatin
Table 3
Dose-limiting
grade III/IV toxicities (N = 50).
| | Toxicities | Number
of patients (%) |
| | Neutropenia | 29 (58) | | Thrombocytopenia | 8 (16) | | Diarrhea | 4 (8) | | Nausea/emesis | 4 (8) | | Asthenia | 2 (4) |
|
|
